Common Mild Side Effects Short-term redness or slight irritation at the injection site Light water retention, especially during the initial weeks Increased appetite Mild headaches (rare and usually transient) Temporary fatigue or lightheadedness immediately after injection Who Should Avoid This Therapy People with an active cancer diagnosis or history of cancer, as GH secretagogues increase cellular replication rates Pregnant or breastfeeding individuals should avoid this therapy due to insufficient safety data on its effects during these stages
Glutamine, a nonessential amino acid with several important functions, accounts for the majority of energy generated in the small intestine along with glutamate and aspartate [131,144]
Instead, it appears to reduce their activity through a different mechanism, possibly by converting the active form of these enzymes to an inactive state (Li et al., 2013
Therefore, UA boosted the anti-tumor activity of sorafenib in tumor xenograft models
10.1016/j.redox.2017.06.010 105 Rodriguez-FernandezI
